Synopsis
Synopsis
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5 Formyltetrahydrofolate
2. 5 Formyltetrahydropteroylglutamate
3. 5-formyltetrahydrofolate
4. 5-formyltetrahydropteroylglutamate
5. Acid, Folinic
6. Calcium Folinate
7. Citrovorum Factor
8. Factor, Citrovorum
9. Folinate, Calcium
10. Folinic Acid
11. Folinic Acid Sf
12. Folinic Acid-sf
13. Leucovorin
14. Leucovorin, (d)-isomer
15. Leucovorin, (dl)-isomer
16. Leucovorin, (r)-isomer
17. Leucovorin, Calcium
18. Leucovorin, Calcium (1:1) Salt
19. Leucovorin, Calcium (1:1) Salt, (dl)-isomer
20. Leucovorin, Calcium (1:1) Salt, Pentahydrate
21. Leucovorin, Monosodium Salt
22. Leukovorin
23. Leukovorum
24. Monosodium Salt Leucovorin
25. N(5)-formyltetrahydrofolate
26. Wellcovorin
1. Calcium Folinate
2. Calcium Citrovorum Factor
3. Folinic Acid Calcium Salt
4. Folinic Acid-sf, Calcium Salt
5. (+)-l-folinic Acid, Calcium Salt
6. 1492-18-8
7. Nsc3590
8. Sr-05000001662
9. Pharmakon1600-01500364
10. Nsc757083
11. Nsc-757083
12. Sr-05000001662-1
13. Sr-05000001662-2
14. Glutamic Acid,6,7,8-tetrahydro-4-hydroxy-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), L-
15. L-glutamic Acid,4,5,6,7,8-hexahydro-4-oxo-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), (s)-
Molecular Weight | 513.5 g/mol |
---|---|
Molecular Formula | C20H23CaN7O7+2 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 513.1284869 g/mol |
Monoisotopic Mass | 513.1284869 g/mol |
Topological Polar Surface Area | 216 Ų |
Heavy Atom Count | 35 |
Formal Charge | 2 |
Complexity | 911 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AF - Detoxifying agents for antineoplastic treatment
V03AF03 - Calcium folinate
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-10-18
Pay. Date : 2024-09-19
DMF Number : 40427
Submission : 2024-09-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-26
Pay. Date : 2024-06-10
DMF Number : 38878
Submission : 2023-09-27
Status : Active
Type : II
Certificate Number : R1-CEP 2011-370 - Rev 00
Issue Date : 2019-07-26
Type : Chemical
Substance Number : 978
Status : Valid
NDC Package Code : 63660-0012
Start Marketing Date : 2012-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-03-02
Pay. Date : 2018-02-20
DMF Number : 5261
Submission : 1984-01-23
Status : Active
Type : II
Certificate Number : R1-CEP 1996-055 - Rev 08
Issue Date : 2023-05-19
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 218MF10352
Registrant's Address : Weisshausmatte CH-6460 Altdorf Switzerland
Initial Date of Registration : 2006-03-17
Latest Date of Registration : --
NDC Package Code : 54784-009
Start Marketing Date : 1984-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2021-04-05
Registration Number : 20210405-210-J-686
Manufacturer Name : Merck & Cie KmG@Dottikon Exclusive Synthesis AG
Manufacturer Address : Im Laternenacker 5,CH-8200 Schaffhausen, Switzerland@Hembrunnstrasse 17 CH-5605 Dottikon Switzerland
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-08-16
Pay. Date : 2019-06-24
DMF Number : 33740
Submission : 2019-05-18
Status : Active
Type : II
NDC Package Code : 68034-100
Start Marketing Date : 2019-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-04
Pay. Date : 2013-09-25
DMF Number : 5046
Submission : 1983-06-30
Status : Active
Type : II
Certificate Number : CEP 2013-176 - Rev 02
Issue Date : 2024-04-02
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 221MF10021
Registrant's Address : Via Figino 6,6917 Barbengo/Lugano, Switzerland
Initial Date of Registration : 2009-01-28
Latest Date of Registration : --
NDC Package Code : 54239-002
Start Marketing Date : 1983-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2022-01-05
Registration Number : 20220105-210-J-1193
Manufacturer Name : Cerbios pharma SA
Manufacturer Address : Via Figino 6, 6917 Barbengo/Lugano, Switzerland
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25334
Submission : 2011-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16718
Submission : 2003-07-18
Status : Inactive
Type : II
Certificate Number : CEP 2004-009 - Rev 04
Issue Date : 2024-04-15
Type : Chemical
Substance Number : 978
Status : Valid
Registration Number : 227MF10147
Registrant's Address : 6, rue des Iles CH-2108 COUVET Switzerland
Initial Date of Registration : 2015-05-20
Latest Date of Registration : --
NDC Package Code : 68034-100
Start Marketing Date : 2019-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3715
Submission : 1980-02-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5429
Submission : 1984-07-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25334
Submission : 2011-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-25
DMF Number : 5046
Submission : 1983-06-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16718
Submission : 2003-07-18
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-08-16
Pay. Date : 2019-06-24
DMF Number : 33740
Submission : 2019-05-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-26
Pay. Date : 2024-06-10
DMF Number : 38878
Submission : 2023-09-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-02
Pay. Date : 2018-02-20
DMF Number : 5261
Submission : 1984-01-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-18
Pay. Date : 2024-09-19
DMF Number : 40427
Submission : 2024-09-04
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10232
Submission : 1993-03-06
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5429
Submission : 1984-07-09
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3715
Submission : 1980-02-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm : #125 & 126, Sipcot Industrial Complex, Hosur-635 126, Tamilnadu
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Allastir instituted the services in 2010 with a motive to cater the pharmaceutical industry with niche API's. In Allastir we strongly believe in team work and customer satisfaction...
About the Company : Anthem Biosciences is a leading contract research and innovation service provider (CRISP) in Bengaluru, India, which manufactures novel drug actives. Established in 2007, it specia...
About the Company : Cerbios is a privately held company located in Lugano, Switzerland. Cerbios is the ideal CDMO partner from clinical to commercial supply of ADCs, HPAPIs, Proteins and Antibodies. ...
About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...
About the Company : As an EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979 as Calcium Ind...
About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...
About the Company : Established in the year 2004, Sakar is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injec...
About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...
About the Company : Huiyu Pharma, established in Oct. 2010, is a specialized pharmaceutical company focusing on developing and manufacturing high-quality oncology products. At present, products in our...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
ST316 is a first-in-class peptide antagonist of the interaction between β-catenin and its co-activator, BCL9. It is being evaluated for the treatment of colorectal cancer.
Lead Product(s): ST316,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area: Oncology Brand Name: ST316
Study Phase: Phase I/ Phase IIProduct Type: Peptide
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 01, 2024
Lead Product(s) : ST316,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Sapience Enrolls First Patient in Phase 2 Study of ST316 for Colorectal Cancer
Details : ST316 is a first-in-class peptide antagonist of the interaction between β-catenin and its co-activator, BCL9. It is being evaluated for the treatment of colorectal cancer.
Brand Name : ST316
Molecule Type : Peptide
Upfront Cash : Not Applicable
October 01, 2024
Details:
Through the collaboration, Lisata will utilize MRD technology to detect ctDNA in a clinical trial evaluating CEND-1 (certepetide) combined with chemotherapy for the treatment of pancreatic cancer.
Lead Product(s): Certepetide,Panitumumab,Calcium Folinate
Therapeutic Area: Oncology Brand Name: CEND-1
Study Phase: Phase I/ Phase IIProduct Type: Peptide
Sponsor: Lisata Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration July 18, 2024
Lead Product(s) : Certepetide,Panitumumab,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Lisata Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Haystack Oncology and Lisata Therapeutics Start Collaboration to Use MRD™ Tech
Details : Through the collaboration, Lisata will utilize MRD technology to detect ctDNA in a clinical trial evaluating CEND-1 (certepetide) combined with chemotherapy for the treatment of pancreatic cancer.
Brand Name : CEND-1
Molecule Type : Peptide
Upfront Cash : Undisclosed
July 18, 2024
Details:
Enlituo (cetuximab beta) is a EGFR inhibitor indicated in combination with the FOLFIRI regimen as a first-line treatment for RAS/BRAF wild-type metastatic colorectal cancer (mCRC).
Lead Product(s): Cetuximab,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area: Oncology Brand Name: Enlituo
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 26, 2024
Lead Product(s) : Cetuximab,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA
Details : Enlituo (cetuximab beta) is a EGFR inhibitor indicated in combination with the FOLFIRI regimen as a first-line treatment for RAS/BRAF wild-type metastatic colorectal cancer (mCRC).
Brand Name : Enlituo
Molecule Type : Large molecule
Upfront Cash : Not Applicable
June 26, 2024
Details:
Natrunix is an immunoglobulin cloned from healthy human donor which blocks IL-1α it is being investigated in combination with chemotherapy regimen for pancreatic cancer.
Lead Product(s): Vilamakitug,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area: Oncology Brand Name: Natrunix
Study Phase: Phase I/ Phase IIProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 18, 2024
Lead Product(s) : Vilamakitug,Irinotecan Hydrochloride,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
XBiotech's Phase 1/2 Study Shows Promise for Pancreatic Cancer
Details : Natrunix is an immunoglobulin cloned from healthy human donor which blocks IL-1α it is being investigated in combination with chemotherapy regimen for pancreatic cancer.
Brand Name : Natrunix
Molecule Type : Large molecule
Upfront Cash : Not Applicable
June 18, 2024
Details:
Ipsen acquired exclusive commercialization rights for Onivyde, an encapsulated formulation of irinotecan as a first-line treatment for metastatic adenocarcinoma of the pancreas in the US.
Lead Product(s): Irinotecan Hydrochloride,Fluorouracil,Calcium Folinate
Therapeutic Area: Oncology Brand Name: Onivyde
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Ipsen
Deal Size: $1,025.0 million Upfront Cash: $575.0 million
Deal Type: Acquisition March 27, 2024
Lead Product(s) : Irinotecan Hydrochloride,Fluorouracil,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Ipsen
Deal Size : $1,025.0 million
Deal Type : Acquisition
Merrimack Receives $225 Million Milestone Payment from Ipsen
Details : Ipsen acquired exclusive commercialization rights for Onivyde, an encapsulated formulation of irinotecan as a first-line treatment for metastatic adenocarcinoma of the pancreas in the US.
Brand Name : Onivyde
Molecule Type : Small molecule
Upfront Cash : $575.0 million
March 27, 2024
Details:
Astellas' Vyloy (zolbetuximab), a CLDN 18.2 inhibitor has been approved in combination with chemotherapy for HER2-negative, CLDN18.2 positive, unresectable, advanced or recurrent gastric cancer.
Lead Product(s): Zolbetuximab,Oxaliplatin,Calcium Folinate
Therapeutic Area: Oncology Brand Name: VYLOY
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 26, 2024
Lead Product(s) : Zolbetuximab,Oxaliplatin,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Details : Astellas' Vyloy (zolbetuximab), a CLDN 18.2 inhibitor has been approved in combination with chemotherapy for HER2-negative, CLDN18.2 positive, unresectable, advanced or recurrent gastric cancer.
Brand Name : VYLOY
Molecule Type : Large molecule
Upfront Cash : Not Applicable
March 26, 2024
Details:
AbilityPharma to obtain financing for the clinical development of ABTL0812 in combination with folfirinox. It is being evaluated in Phase I/II clinical trial studies for Metastatic Pancreatic Cancer.
Lead Product(s): ABTL0812,Calcium Folinate,Fluorouracil
Therapeutic Area: Oncology Brand Name: ABTL0812
Study Phase: Phase I/ Phase IIProduct Type: Small molecule
Sponsor: CTI Life Sciences
Deal Size: $7.6 million Upfront Cash: Undisclosed
Deal Type: Financing March 11, 2024
Lead Product(s) : ABTL0812,Calcium Folinate,Fluorouracil
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : CTI Life Sciences
Deal Size : $7.6 million
Deal Type : Financing
AbilityPharma Raises €7M to Advance Phase 2b ABTL0812 for Metastatic Pancreatic Cancer
Details : AbilityPharma to obtain financing for the clinical development of ABTL0812 in combination with folfirinox. It is being evaluated in Phase I/II clinical trial studies for Metastatic Pancreatic Cancer.
Brand Name : ABTL0812
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 11, 2024
Details:
Oncotelic's lead product candidate, OT-101, is a TGF beta-2 inhibitor combined with folfirinox. It is currently under evaluation in Phase 2/3 trials for treating pancreatic ductal adenocarcinoma.
Lead Product(s): OT-101,Calcium Folinate,Fluorouracil
Therapeutic Area: Oncology Brand Name: OT-101
Study Phase: Phase II/ Phase IIIProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 04, 2024
Lead Product(s) : OT-101,Calcium Folinate,Fluorouracil
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Invitation to Participate in STOP-PC Clinical Trial
Details : Oncotelic's lead product candidate, OT-101, is a TGF beta-2 inhibitor combined with folfirinox. It is currently under evaluation in Phase 2/3 trials for treating pancreatic ductal adenocarcinoma.
Brand Name : OT-101
Molecule Type : Large molecule
Upfront Cash : Not Applicable
March 04, 2024
Details:
Onivyde (irinotecan), liposomal injection is a small molecule drug that blocks an enzyme called topoisomerase I. It is being developed for the treatment of metastatic pancreatic adenocarcinoma.
Lead Product(s): Irinotecan Hydrochloride,Fluorouracil,Calcium Folinate
Therapeutic Area: Oncology Brand Name: Onivyde
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 13, 2024
Lead Product(s) : Irinotecan Hydrochloride,Fluorouracil,Calcium Folinate
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Onivyde Regimen Approved by FDA as First-Line Therapy in Metastatic Pancreatic Cancer
Details : Onivyde (irinotecan), liposomal injection is a small molecule drug that blocks an enzyme called topoisomerase I. It is being developed for the treatment of metastatic pancreatic adenocarcinoma.
Brand Name : Onivyde
Molecule Type : Small molecule
Upfront Cash : Not Applicable
February 13, 2024
Details:
AMP945 (narmafotinib) is a novel focal adhesion kinase (FAK) inhibitor. It is being evaluated in precliical studies for the treatment of patients with pancreatic cancer.
Lead Product(s): AMP945,Calcium Folinate,Fluorouracil
Therapeutic Area: Oncology Brand Name: AMP945
Study Phase: IND EnablingProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 17, 2024
Lead Product(s) : AMP945,Calcium Folinate,Fluorouracil
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
FDA Clearance of Amplia's IND for Pancreatic Cancer Trial in US
Details : AMP945 (narmafotinib) is a novel focal adhesion kinase (FAK) inhibitor. It is being evaluated in precliical studies for the treatment of patients with pancreatic cancer.
Brand Name : AMP945
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 17, 2024
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Vial
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Vial
Dosage Strength : 350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
RLD : No
TE Code : AB
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Approval Date : 2021-05-19
Application Number : 74544
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : LEUCOVORIN CALCIUM PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL
Approval Date : 1999-02-26
Application Number : 40258
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code :
Brand Name : WELLCOVORIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 50MG BASE/VIAL
Approval Date : 1989-01-23
Application Number : 89465
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AP
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 50MG BASE/VIAL
Approval Date : 2023-07-10
Application Number : 217021
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code :
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : EQ 60MG BASE/VIAL
Approval Date : 1987-01-30
Application Number : 8107
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Approval Date : 2020-07-30
Application Number : 211132
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 1987-10-14
Application Number : 71600
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : LEUCOVORIN CALCIUM
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 350MG BASE/VIAL
Approval Date : 1999-12-15
Application Number : 40262
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AP
Brand Name : LEUCOVORIN CALCIUM PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 50MG BASE/VIAL
Approval Date : 2012-09-06
Application Number : 200753
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : LEUCOVORIN CALCIUM PRESERVATIVE FREE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL
Approval Date : 2012-09-06
Application Number : 200753
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Regulatory Info : Generic
Registration Country : Turkey
Brand Name : ANTREX
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging : 100 Tablet Plastic Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : Citofolin
Dosage Form :
Dosage Strength : Os Soluz 10 Vials 15 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Citofolin
Dosage Form :
Dosage Strength : 6 Ampoules Im Ev 3 Mg + 6 Vials Solv 1 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Citofolin
Dosage Form :
Dosage Strength : 6 Ampoules Im Ev 15 Mg + 6 Vials Solv 1 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Calciumfolinat Hospira
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 10 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Folidar
Dosage Form :
Dosage Strength : 30 Cpr 15 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Calcium folinate Sandoz eco
Dosage Form : Inj Solution
Dosage Strength : 500mg/50ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : Calciumfolinate Teva
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Folaren
Dosage Form :
Dosage Strength : 10 Cpr 15 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Calciumfolinat Ebewe
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Dosage Form :
Dosage Strength : Os Soluz 10 Vials Of 8 Ml
Price Per Pack (Euro) : 11.06
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : Os Soluz 10 Vials 15 Ml
Price Per Pack (Euro) : 13.87
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : 10 Cpr 15 Mg
Price Per Pack (Euro) : 8
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : Os Soluz 10 Vials 15 Mg
Price Per Pack (Euro) : 8.2
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : 6 Ampoules Im Ev 3 Mg + 6 Vials Solv 1 Ml ...
Price Per Pack (Euro) : 4.13
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : 6 Ampoules Im Ev 15 Mg + 6 Vials Solv 1 Ml...
Price Per Pack (Euro) : 7.9
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : 30 Cpr Riv 0.1 Mg + 0.5 Mg
Price Per Pack (Euro) : 4.79
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Dosage Form :
Dosage Strength : To 6 Vials Im Ev + 6 Vials Solv 1.5 Ml
Price Per Pack (Euro) : 8.15
Published in :
Country : Italy
RX/OTC/DISCN : Class C
BIOHEALTH PHARMACEUTICALS Srl
Dosage Form :
Dosage Strength : 10 Cpr 15 Mg
Price Per Pack (Euro) : 6.3
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
BIOHEALTH PHARMACEUTICALS Srl
Dosage Form :
Dosage Strength : Os Soluz 10 Vials 15 Mg
Price Per Pack (Euro) : 8.25
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?